We facilitate the work of our world leading researchers in infectious disease, stem cell biology and personalised cancer medicine to improve outcomes for patients.
Company Details
- Founded
- 2018
- Address
- 19 Innovation Walk, Building 76 - Level 3,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- M2M Pharmaceuticals Ltd.
- HQ
- Clayton, Victoria
- Competitors
- Swiss National Science Foundation SNSF, Skin Ageing and Challenges, Psaio Tx, M2M Pharmaceuticals Ltd, Drug Discovery Unit, University of Dundee, Swiss Biobanking Platform, AusBiotech, Veksthuset for verdiskaping – UiO Growth House, Graduate School for Cellular and Biomedical Sciences, University of Bern, Nexomics @ Peter MacCallum Cancer Centre.
Monash Bdi Organoid Program Questions
Monash Bdi Organoid Program's website is https://www.monash.edu/discovery-institute/research/organoid-program
Monash Bdi Organoid Program's LinkedIn profile is https://au.linkedin.com/company/monash-bdi-organoid-program
Monash Bdi Organoid Program's industry is
Biotechnology Research
Monash Bdi Organoid Program's top competitors are
Swiss National Science Foundation Snsf,
Skin Ageing And Challenges,
Psaio Tx,
M2m Pharmaceuticals Ltd,
Drug Discovery Unit, University Of Dundee,
Swiss Biobanking Platform,
Ausbiotech,
Veksthuset For Verdiskaping – Uio Growth House,
Graduate School For Cellular And Biomedical Sciences, University Of Bern,
Nexomics @ Peter Maccallum Cancer Centre.
Monash Bdi Organoid Program's categories are Biotechnology Research
Monash Bdi Organoid Program's founding year is 2018
